HARBOURVEST PARTNERS LLC - Q2 2021 holdings

$1.05 Billion is the total value of HARBOURVEST PARTNERS LLC's 51 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 56.8% .

 Value Shares↓ Weighting
W  Wayfair, Inc.$335,324,000
+0.3%
1,062,1260.0%32.05%
-28.5%
MNDY NewMonday.com$274,540,0001,227,874
+100.0%
26.24%
SWI  Solarwinds Corp.$125,648,000
-3.2%
7,439,2000.0%12.01%
-31.0%
BHG NewBright Health Group, Inc.$72,376,0004,217,715
+100.0%
6.92%
EVLO  Evelo Biosciences, Inc.$42,093,000
+28.4%
3,063,5050.0%4.02%
-8.5%
RUBY  Rubius Therapeutics, Inc.$24,090,000
-7.9%
986,8780.0%2.30%
-34.3%
FTCH NewFarfetch Ltd.ordinary shares cla$22,295,000442,716
+100.0%
2.13%
WHD NewCactus, Inc.$14,427,000392,896
+100.0%
1.38%
KLDO  Kaleido BioSciences, Inc.$13,644,000
-8.1%
1,833,8320.0%1.30%
-34.5%
AXLA  Axcella Health, Inc.$11,260,000
-15.8%
2,807,9810.0%1.08%
-40.0%
RLAY  Relay Therapeutics, Inc.$10,845,000
+5.8%
296,4020.0%1.04%
-24.5%
RBLX SellRoblox Corporation$9,336,000
-33.8%
103,755
-52.3%
0.89%
-52.9%
LC  LendingClub Corp.$9,309,000
+9.8%
513,4400.0%0.89%
-21.8%
NARI SellInari Medical$8,264,000
-47.6%
88,598
-39.9%
0.79%
-62.7%
SGTX  Sigilon Therapeutics, Inc.$7,948,000
-52.0%
740,7400.0%0.76%
-65.8%
DELL NewDell, Inc.$6,703,00067,253
+100.0%
0.64%
CVRX NewCVRx, Inc.$5,977,000213,479
+100.0%
0.57%
TWLO  Twilio, Inc.$5,744,000
+15.7%
14,5720.0%0.55%
-17.6%
UPST NewUpstart Holdings, Inc.$5,652,00045,251
+100.0%
0.54%
ZUO BuyZuora, Inc.$5,158,000
+112.6%
299,032
+82.5%
0.49%
+51.7%
IBRX SellImmunityBio, Inc.$4,794,000
-41.8%
335,709
-3.3%
0.46%
-58.6%
PGNY NewProgyny, Inc.$2,799,00047,441
+100.0%
0.27%
LOV  Spark Networks SEsponsored adr$2,595,000
-30.5%
501,0260.0%0.25%
-50.5%
U  Unity Software$2,405,000
+9.5%
21,8990.0%0.23%
-22.0%
TENB NewTenable Holdings, Inc.$2,275,00055,029
+100.0%
0.22%
ROOT NewRoot, Inc.$2,211,000204,314
+100.0%
0.21%
PATH NewUiPath, Inc.$2,162,00031,830
+100.0%
0.21%
EB SellEventbrite, Inc.$2,015,000
-75.5%
106,064
-71.4%
0.19%
-82.5%
AFRM  Affirm, Inc.$1,889,000
-4.8%
28,0530.0%0.18%
-32.0%
YEXT  Yext, Inc.$1,645,000
-1.3%
115,1470.0%0.16%
-29.9%
ABCL NewAbCellera Biologics, Inc.$1,302,00059,200
+100.0%
0.12%
MCRB  Seres Therapeutics, Inc.$1,177,000
+15.8%
49,3630.0%0.11%
-16.9%
NRIX NewNurix Therapeutics, Inc.$1,171,00044,141
+100.0%
0.11%
ACVA NewACV Auctions, Inc.$1,026,00040,049
+100.0%
0.10%
CSLT  Castlight Health, Inc.$918,000
+74.2%
349,0700.0%0.09%
+23.9%
PACB  Pacific Biosciences of California, Inc.$821,000
+5.0%
23,4840.0%0.08%
-25.7%
DCT  Duck Creek Technologies, Inc.$631,000
-3.7%
14,5080.0%0.06%
-31.8%
CTMX  Cytomx Therapeutics, Inc.$501,000
-18.1%
79,1930.0%0.05%
-41.5%
RPTX BuyRepare Therapeutics, Inc.$460,000
+22.0%
14,747
+20.1%
0.04%
-13.7%
TRVN  Trevena, Inc.$395,000
-5.7%
233,8500.0%0.04%
-32.1%
ALGS NewAligos Therapeutics, Inc.$383,00018,783
+100.0%
0.04%
JNCE BuyJounce Therapeutics, Inc.$362,000
+76.6%
53,260
+167.3%
0.04%
+29.6%
BILL NewBill.com Holdings, Inc.$324,0001,770
+100.0%
0.03%
OYST SellOyster Point Pharma, Inc.$267,000
-57.3%
15,545
-54.5%
0.03%
-69.0%
YMTX  Yumanity$257,000
-35.6%
22,0300.0%0.02%
-53.7%
PMVP  PMV Pharmaceuticals$263,000
+4.0%
7,6920.0%0.02%
-26.5%
EPZM  Epizyme, Inc.$205,000
-4.7%
24,6860.0%0.02%
-31.0%
NXTC  NextCure, Inc.$81,000
-19.8%
10,0440.0%0.01%
-42.9%
METC  Ramaco Resources, Inc.$82,000
+30.2%
14,9510.0%0.01%0.0%
RAPT SellRapt Therapeutics, Inc.$56,000
-79.6%
1,777
-85.6%
0.01%
-86.5%
HNRG  Hallador Energy Resources, Inc.$38,000
+40.7%
14,2700.0%0.00%0.0%
AM ExitAntero Midstream GP$0-3,316
-100.0%
-0.00%
FROG ExitJfrog$0-10,756
-100.0%
-0.06%
ExitMarinus Pharmaceuticals, Inc.$0-30,962
-100.0%
-0.06%
SPT ExitSprout Social, Inc.$0-8,692
-100.0%
-0.07%
NET ExitCloudFlare, Inc.$0-9,278
-100.0%
-0.09%
CRWD ExitCrowdStrike Holdings, Inc.$0-13,676
-100.0%
-0.34%
DASH ExitDoorDash, Inc.$0-29,903
-100.0%
-0.53%
DDOG ExitDatadog, Inc.$0-93,162
-100.0%
-1.04%
SNOW ExitSnowflake Computing, Inc.$0-318,233
-100.0%
-9.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26
13F-HR2022-05-13
13F-HR2022-02-14

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Export HARBOURVEST PARTNERS LLC's holdings